DESCRIPTION OF BUSINESS (Details)
$ / shares in Units, ر.س in Millions |
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
Jul. 16, 2025
USD ($)
day
|
Apr. 08, 2025
USD ($)
|
Oct. 31, 2024
USD ($)
|
Apr. 30, 2030
USD ($)
|
Apr. 30, 2026
USD ($)
$ / shares
shares
|
Nov. 30, 2025
USD ($)
|
Sep. 30, 2025
USD ($)
shares
|
Oct. 31, 2024
USD ($)
shares
|
Aug. 31, 2024
USD ($)
$ / shares
shares
|
Mar. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2025
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2025
USD ($)
|
Nov. 04, 2025
USD ($)
|
Feb. 28, 2025
USD ($)
|
Feb. 28, 2025
SAR (ر.س)
|
Feb. 24, 2025
USD ($)
|
Feb. 24, 2025
SAR (ر.س)
|
Jun. 30, 2022
USD ($)
|
Apr. 29, 2022
USD ($)
|
Apr. 29, 2022
SAR (ر.س)
|
Feb. 27, 2022
USD ($)
|
Feb. 27, 2022
SAR (ر.س)
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
|
|
$ 1,028,344,000
|
$ 366,171,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated deficit |
|
|
|
|
|
|
|
|
|
|
|
16,639,089,000
|
|
|
$ 15,610,745,000
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
2,279,300,000
|
|
|
2,279,300,000
|
|
|
|
|
|
|
|
|
|
|
| Call Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for purchased capped call transactions |
|
$ 118,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 Underwriting Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
$ 718,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2026 Underwriting Agreement | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
$ 291,500,000
|
$ 291,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | 2024 Subscription Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
$ 1,025,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | 2024 Subscription Agreement | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
37,471,793
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
$ 1,025,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series A Derivative Liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
|
|
|
|
|
$ 1,000,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
|
|
997,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series A Derivative Liability | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
|
|
$ 997,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series B Derivative Liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
|
|
|
|
$ 750,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
|
$ 749,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series B Derivative Liability | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
|
|
|
|
$ 750,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
|
|
$ 749,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series C Redeemable Convertible Preferred Stock | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
55,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
$ 550,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayar | Redeemable Convertible Preferred Stock | Series C Redeemable Convertible Preferred Stock | Subsequent Event | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
55,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
$ 550,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Underwriter | 2024 Underwriting Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, underwriter exercise period |
|
|
|
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SMB | 2025 Subscription Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
13,715,121
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
$ 300,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
$ 299,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, arithmetic average daily volume-weighted average price of common stock, consecutive trading days | day |
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SMB | 2025 Subscription Agreement | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds received |
|
|
|
|
|
|
$ 299,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SMB | 2026 Subscription Agreement | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration to be received on agreement |
|
|
|
|
200,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SIDF |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000,000
|
|
|
|
|
|
|
|
|
|
$ 1,400,000,000
|
ر.س 5,190
|
| ABL Credit Facility | Revolving Credit Facility | Line of Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, term |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,000,000,000.0
|
|
|
|
|
|
|
$ 1,000,000,000.0
|
|
|
|
|
| GIB Facility Agreement | Revolving Credit Facility | Line of Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 266,100,000
|
ر.س 1,000
|
|
|
| 2025 GIB Credit Facility | Revolving Credit Facility | Line of Credit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 506,200,000
|
ر.س 1,900
|
$ 506,200,000
|
ر.س 1,900
|
|
|
|
|
|
| DDTL Credit Facility | Secured Debt | Delayed Draw Term Loan (DDTL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, term |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
|
$ 1,980,000,000
|
|
|
$ 750,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DDTL Credit Facility | Secured Debt | Delayed Draw Term Loan (DDTL) | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from lines of credit |
|
|
|
|
500,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DDTL Credit Facility | Secured Debt | Delayed Draw Term Loan (DDTL) | Subsequent Event | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from lines of credit |
|
|
|
|
500,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2025 DDTL Credit Facility | Secured Debt | Delayed Draw Term Loan (DDTL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,980,000,000
|
|
|
|
|
|
|
|
|
|
| DDTL Amendment | Secured Debt | Delayed Draw Term Loan (DDTL) | Subsequent Event |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line of credit facility, increase (decrease), net |
|
|
|
|
500,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line of Credit Facility, Maximum Amount Outstanding During Period |
|
|
|
|
2,500,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DDTL Amendment | Secured Debt | Delayed Draw Term Loan (DDTL) | Subsequent Event | Related Party |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum borrowing capacity |
|
|
|
|
2,500,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Line of credit facility, increase (decrease), net |
|
|
|
|
$ 500,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2030 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
1,100,000,000
|
|
|
1,100,000,000
|
|
|
|
|
|
|
|
|
|
|
| 2030 Notes | Call Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment for purchased capped call transactions |
|
118,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2030 Notes | Convertible Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
$ 1,100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
5.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt |
|
$ 1,081,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt used for repurchase |
|
$ 931,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Senior Notes Due 2026 | Convertible Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
1.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, repurchased face amount |
|
$ 1,052,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2031 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
975,000,000.0
|
|
|
975,000,000.0
|
|
|
|
|
|
|
|
|
|
|
| 2031 Notes | Convertible Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
$ 975,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt |
|
|
|
|
|
$ 962,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt used for repurchase |
|
|
|
|
|
748,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2026 Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
|
$ 204,300,000
|
|
|
$ 204,300,000
|
|
|
|
|
|
|
|
|
|
|
| 2026 Notes | Convertible Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
|
|
|
|
|
$ 2,012,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
1.25%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt |
|
|
|
|
|
|
|
|
|
|
$ 1,986,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument, repurchased face amount |
|
1,052,500,000
|
|
|
|
$ 755,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from convertible debt used for repurchase |
|
$ 931,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|